Beth Marcoux Llc in Alton, NH - Physical Therapist

Beth Marcoux Llc is a Physical Therapist based in Alton, New Hampshire. Beth Marcoux Llc is licensed to practice in New Hampshire (license number 3708) and their current practice location is 42 Campfire Circle, Alton, New Hampshire. It can be reached at their office (for appointments etc.) via phone at (603) 452-4263.

NPI number for Beth Marcoux Llc is 1073912341 and their current mailing address is P.o. Box 1714, Wolfeboro, New Hampshire. Beth Marcoux Llc does not participate in medicare program and thus does not accept medicare assignments. The facility's NPI Number is 1073912341.

Contact Information

	Beth Marcoux Llc
	42 Campfire Circle, Alton, NH 03809
	(603) 452-4263
	Not Available

Healthcare Provider's Profile

Full Name	Beth Marcoux Llc
Type	Facility
Speciality	Physical Therapist
Location	42 Campfire Circle, Alton, New Hampshire
Accepts Medicare Assignments	Does not participate in Medicare Program. The facility may not accept medicare assignment.

NPI Data:

NPI Number: 1073912341
Provider Enumeration Date: 08/22/2014
Last Update Date: 08/22/2014

Medical Identifiers

Medical identifiers for Beth Marcoux Llc such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1073912341	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
225100000X	Physical Therapist	3708 (New Hampshire)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Beth Marcoux Llc is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Beth Marcoux Llc P.o. Box 1714, Wolfeboro, NH 03894 Ph: (603) 452-4263	Beth Marcoux Llc 42 Campfire Circle, Alton, NH 03809 Ph: (603) 452-4263

News Archive

Cambridge Heart fourth quarter total revenue decreases to $557,000

Cambridge Heart, Inc., a developer of non-invasive diagnostic tests for cardiac disease, today reported results for its fourth quarter and full year ended December 31, 2011. Full financial statements and corresponding commentary can be found in the Company's Form 10-K, which will be filed with the Securities and Exchange Commission on March 30, 2012.

Research grows "mini-livers" to reduce use of animals in science

Research that has for the first time successfully grown "mini-livers" from adult mouse stem cells has won the UK's international prize for the scientific and technological advance with the most potential to replace, reduce or refine the use of animals in science (the 3Rs).

Study: Indoor tanning may be marker of eating disorder-related behaviors

High school students who use indoor tanning also have higher rates of unhealthy weight control behaviors-such as taking diet pills or vomiting to lose weight, reports a study in the April Journal of Developmental & Behavioral Pediatrics, the official journal of the Society for Developmental and Behavioral Pediatrics.

Scientists design new drugs that may help prevent spread of aggressive pancreatic cancers

Cancer is among the leading causes of death worldwide> There were approximately 14m new cases diagnosed and 8.2m cancer related deaths in 2012. This figure is expected to rise of about 70% over the next two decades.

Orexigen's Empatic Phase 2b results demonstrate weight loss

Orexigen Therapeutics, Inc. today announced that its 24-week, Phase 2b trial for Empatic(TM) (bupropion SR/zonisamide SR), the Company's second late stage investigational combination drug for the treatment of obesity, met its primary efficacy endpoint by demonstrating statistically significantly greater weight loss for both Empatic doses compared to monotherapies and placebo.

Beth Marcoux Llc - Physical Therapist in Alton, NH